| A Clinical Study of SHR-5421 in Patients With Multiple Myeloma (NCT07652281) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-07-23 |
| Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China (NCT07757152) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-07-23 |
| Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. (NCT07755436) | ArriVent BioPharma, Inc. | 2026-07-23 |
| A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity (NCT07725809) | Pfizer | 2026-07-23 |
| Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants (NCT07762287) | Bayer | 2026-07-22 |
| Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older (NCT07734649) | Sanofi | 2026-07-22 |
| A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss (NCT07663630) | Pfizer | 2026-07-22 |
| A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period (NCT07733089) | Zealand Pharma | 2026-07-22 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants (NCT07722299) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2026-07-21 |
| TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT (NCT07302776) | Stanford University | 2026-07-21 |
| A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight (NCT07693231) | Boehringer Ingelheim | 2026-07-21 |
| Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer (NCT07363408) | City of Hope Medical Center | 2026-07-21 |
| A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a Placebo (NCT07662148) | Biogen | 2026-07-21 |
| A Study to Investigate the Relative Bioavailability of 2 Tablet Formulations and the Effect of Food on the Pharmacokinetics of BGB-58067 in Healthy Participants (NCT07712640) | BeOne Medicines | 2026-07-21 |
| A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes (NCT07668999) | Sinomune Pharmaceutical Co., Ltd | 2026-07-21 |
| A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy Participants (NCT07700953) | Abbisko Therapeutics Co, Ltd | 2026-07-21 |
| A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005) (NCT07697625) | Merck Sharp & Dohme LLC | 2026-07-20 |
| A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases (NCT07712939) | Candid Therapeutics | 2026-07-20 |
| Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet) (NCT07714317) | Shanghai Zhongshan Hospital | 2026-07-20 |
| Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS) (NCT07293546) | FOXG1 Research Foundation | 2026-07-20 |
| QLF4113 in Participants With Metastatic Prostate Cancer (NCT07636707) | Qilu Pharmaceutical Co., Ltd. | 2026-07-20 |
| REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma (NCT07594106) | Regeneron Pharmaceuticals | 2026-07-20 |
| A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma (NCT07726160) | Institute of Hematology & Blood Diseases Hospital, China | 2026-07-20 |
| Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets (NCT07608666) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-20 |
| Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers (NCT07672574) | Agomab Spain S.L.U. | 2026-07-20 |
| A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma (NCT07732023) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-07-20 |
| A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region (NCT07710664) | Newish Biotech (Wuxi) Co., Ltd. | 2026-07-20 |
| Study of D3L-002 in Subjects With Advanced Solid Tumors (NCT07667842) | D3 Bio (Wuxi) Co., Ltd | 2026-07-18 |
| A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults (NCT07697846) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-07-18 |
| A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors (NCT07703878) | Gilead Sciences | 2026-07-17 |
| A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function (NCT07713758) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2026-07-17 |
| Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors (NCT07375290) | Children's Hospital Medical Center, Cincinnati | 2026-07-17 |
| A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors (NCT07629258) | Groovy Medicine (Hangzhou) Ltd. | 2026-07-17 |
| A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant (NCT07710729) | Novo Nordisk A/S | 2026-07-17 |
| Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates (NCT07703514) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-07-17 |
| A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood (NCT07656792) | Boehringer Ingelheim | 2026-07-17 |
| A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283 (NCT07712393) | GlaxoSmithKline | 2026-07-17 |
| Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA (NCT07620314) | Chinese PLA General Hospital | 2026-07-16 |
| Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents (NCT07693426) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2026-07-16 |
| MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer (NCT06549751) | Marker Therapeutics, Inc. | 2026-07-16 |
| A Study in Healthy Men to Test How BI 1815368 is Processed in the Body (NCT07693218) | Boehringer Ingelheim | 2026-07-16 |
| A Phase I Study of CS5007 in Participants With Advanced Solid Tumors (NCT07622524) | CStone Pharmaceuticals | 2026-07-16 |
| Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder (NCT07102524) | TESS Research Foundation | 2026-07-15 |
| Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis. (NCT07571486) | Assistance Publique - Hôpitaux de Paris | 2026-07-15 |
| Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma (NCT06968195) | Roswell Park Cancer Institute | 2026-07-15 |
| Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma (NCT07725380) | H. Lee Moffitt Cancer Center and Research Institute | 2026-07-15 |
| Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers (NCT07531316) | Virginia Commonwealth University | 2026-07-15 |
| Riptylimab for the Treatment of Optic Neuritis and Myelitis Spectrum Diseases (NCT07685678) | Zhongming Qiu | 2026-07-15 |
| A Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for Moderate-to-Severe CSU With Inadequate Response to Second-Generation H1 Antihistamines (NCT07665996) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2026-07-15 |
| GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT07489287) | Roswell Park Cancer Institute | 2026-07-15 |
| Regenerative Medicine for Joint Hypermobility and Instability (NCT07688096) | Manhattan Pain Medicine, PLLC | 2026-07-15 |
| A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors (NCT07624864) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2026-07-15 |
| A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors (NCT07518043) | Shanghai Henlius Biotech | 2026-07-15 |
| Low-Dose Radiotherapy for Alzheimer's Disease (NCT07693140) | Evan Thomas | 2026-07-15 |
| Impact of Sotatercept on Pulmonary Artery and Right Ventricle Remodeling Imaging Assessed With 68Ga-FAPI PET/CT in Patients With PAH (NCT07357974) | University Hospital, Brest | 2026-07-15 |
| A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer (NCT07662720) | Glycyx Therapeutics | 2026-07-15 |
| Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants. (NCT07756996) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2026-07-15 |
| An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT07696377) | Zhongming Qiu | 2026-07-15 |
| A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection (NCT07710560) | Hunan Kelun Pharmaceutical Co., Ltd. | 2026-07-15 |
| A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV (NCT07124559) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-07-15 |
| A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight (NCT07710768) | Novo Nordisk A/S | 2026-07-15 |
| Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets (NCT07300059) | Aspargo Labs, Inc | 2026-07-15 |
| A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer (NCT07621159) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-07-15 |
| Evaluation of Oral THC and CBD in Men and Women (NCT05067387) | University of California, Los Angeles | 2026-07-15 |
| Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma (NCT07416188) | National Institute of Neurological Disorders and Stroke (NINDS) | 2026-07-15 |
| Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA (NCT07237659) | Neutrolis | 2026-07-15 |
| NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma (NCT07211737) | Baylor College of Medicine | 2026-07-15 |
| A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors (NCT07694765) | LaNova Medicines Limited | 2026-07-15 |
| Evaluation of XYA02 in Patients With Advanced Solid Tumors (NCT07670312) | XYone Therapeutics, Inc | 2026-07-15 |
| Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME) (NCT07287202) | Sovargen | 2026-07-14 |
| A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies (NCT07609862) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-07-14 |
| Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants (NCT07680686) | AbbVie | 2026-07-14 |
| A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment (NCT07643155) | Insmed Incorporated | 2026-07-14 |
| A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function (NCT07715149) | InventisBio Co., Ltd | 2026-07-14 |
| A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults (NCT07721402) | Pfizer | 2026-07-14 |
| SL-28 for Advanced Solid Tumours (NCT07341737) | Second Life Therapeutics | 2026-07-13 |
| Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants (NCT07629999) | Bristol-Myers Squibb | 2026-07-13 |
| First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors (NCT07700160) | VelaVigo Bio Inc | 2026-07-13 |
| Hyperemesis Gravidarum Risk Reduction With Metformin (NCT07129473) | University of Southern California | 2026-07-13 |
| Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors (NCT07583654) | West China Hospital | 2026-07-13 |
| Study of AT-587 in Healthy Subjects (NCT07728487) | Atea Pharmaceuticals, Inc. | 2026-07-13 |
| A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa (NCT07709494) | Revagenix, Inc. | 2026-07-13 |
| Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected (NCT06613789) | HIV Vaccine Trials Network | 2026-07-13 |
| HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma (NCT07697339) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-07-10 |
| A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants (NCT07678463) | QuantX Biosciences, Inc. | 2026-07-10 |
| Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects (NCT07584304) | Yuhan Corporation | 2026-07-10 |
| Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions (NCT07675226) | Oscotec Inc. | 2026-07-10 |
| Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) (NCT07706855) | Beijing Gene Key Life Technology Co., Ltd | 2026-07-10 |
| A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer (NCT07538804) | Avistone Biotechnology Co., Ltd. | 2026-07-10 |
| Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants (NCT07397455) | Imperial College London | 2026-07-10 |
| Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria (NCT07224776) | Brigham and Women's Hospital | 2026-07-10 |
| A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma (NCT07681596) | AstraZeneca | 2026-07-09 |
| A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD (NCT07567872) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-07-09 |
| Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML (NCT07355335) | Massachusetts General Hospital | 2026-07-09 |
| CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis (NCT07388277) | Marcela V. Maus, M.D.,Ph.D. | 2026-07-09 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors (NCT07695142) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-09 |
| A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women (NCT07645235) | GlaxoSmithKline | 2026-07-09 |
| A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma (NCT07710690) | Neuregen Therapeutics Co., Ltd. | 2026-07-09 |
| A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function. (NCT07600788) | Ausper Biopharma Co., Ltd. | 2026-07-09 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants (NCT07658638) | Tes Pharma S.r.l. | 2026-07-08 |